With a poor alternating electrical current transmitted through electrodes connected to the scalp, the researchers from the UNC’s (University of North Carolina) School of Medicine successfully aimed a naturally stirring electrical pattern in a particular part of the brain and noticeably advanced depression symptoms in around 70% of participants in a clinical study. The study was published in Translational Psychiatry. The study lays the foundation for larger research studies to employ a particular kind of electrical brain spur known as tACS (transcranial alternating current stimulation) to heal people identified with major depression.
Flavio Frohlich—Associate Professor and Director of the CCNS (Carolina Center for Neurostimulation)—said, “We carried small research of 32 people since this sort of approach had not been performed before. Now that we have recorded how this type of tACS can lower depression symptoms, we can modify our approach to aid many people in a comparatively inexpensive and noninvasive way.” The tACS approach is dissimilar the more common brain stimulation method called tDCS (transcranial direct stimulation), which transmits a stable stream of weak electricity via electrodes connected to different parts of the brain. That move had mixed outcomes in healing different conditions, counting depression. Reportedly, Frohlich’s tACS prototype is newer and has not been analyzed as tDCS. Frohlich’s study focuses on each person’s specific alpha fluctuations, which emerge as waves amid 8 and 12 Hertz on an EEG (electroencephalogram).
Recently, the UNC was in news as its study stated that consuming a small quantity of peanut after immunotherapy might extend allergy treatment advantages. Habitual dietary peanut intake after completing OIT (oral immunotherapy) or SLIT (sublingual immunotherapy) for peanut allergy might give persisted defense against accidental encounters to the allergen, as per to a new study conducted by Edwin Kim. The findings were presented at the annual AAAAI (American Academy of Allergy, Asthma, and Immunology) conference, San Francisco.